Nuo Therapeutics, Inc. financial data

Symbol
AURX on OTC
Location
8285 El Rio, Suite 150, Houston, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 91.4 % -48.7%
Quick Ratio 15 % -47.1%
Debt-to-equity -696 % -686%
Return On Equity 1.03K %
Return On Assets -173 % -9.09%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.1M shares +3.18%
Common Stock, Shares, Outstanding 47.9M shares +2.75%
Entity Public Float 10M USD -72.1%
Common Stock, Value, Issued 4.79K USD +2.75%
Weighted Average Number of Shares Outstanding, Basic 47.5M shares +4.22%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -2.57M USD -3.46%
Nonoperating Income (Expense) 2.22K USD
Net Income (Loss) Attributable to Parent -2.43M USD +2.01%
Earnings Per Share, Basic 0 USD/shares +16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 515K USD -24.7%
Accounts Receivable, after Allowance for Credit Loss, Current 652K USD +98.1%
Inventory, Net 202K USD +20.2%
Assets, Current 1.46M USD +8.93%
Property, Plant and Equipment, Net 347K USD +84.1%
Operating Lease, Right-of-Use Asset 118K USD -37.2%
Assets 1.93M USD +12.1%
Accounts Payable, Current 492K USD +27.6%
Accrued Liabilities, Current 391K USD +48.1%
Liabilities, Current 1.26M USD +76%
Operating Lease, Liability, Noncurrent 40.8K USD -64.5%
Liabilities 2.35M USD +183%
Retained Earnings (Accumulated Deficit) -34.2M USD -7.65%
Stockholders' Equity Attributable to Parent -420K USD -147%
Liabilities and Equity 1.93M USD +12.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.83K USD
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -230K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 47.9M shares +2.75%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -228K USD +59.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 500K USD -26.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.72K USD +41.5%
Deferred Tax Assets, Valuation Allowance 40.7M USD -1.25%
Deferred Tax Assets, Gross 40.7M USD -1.25%
Operating Lease, Liability 115K USD -36%
Depreciation 73.1K USD +378%
Payments to Acquire Property, Plant, and Equipment 230K USD
Lessee, Operating Lease, Liability, to be Paid 124K USD -39.1%
Property, Plant and Equipment, Gross 841K USD +38%
Operating Lease, Liability, Current 73.9K USD +14.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 21.3K USD -74.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 82.7K USD +3.03%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.37K USD -61.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 21.3K USD +0.01%
Deferred Tax Assets, Operating Loss Carryforwards 40.5M USD -1.13%
Preferred Stock, Shares Authorized 1M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 21.3K USD -74.3%
Additional Paid in Capital 33.8M USD +3.43%
Share-based Payment Arrangement, Expense 92K USD +184%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%